Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:2011:391564.
doi: 10.1155/2011/391564. Epub 2011 Oct 27.

HER-2 Evaluation in a Specific Gastric Cancer Population with the Highest Rate of Mortality in Spain

E U Cidon  1 , R G Centeno, E G Lagarto, J I Peral
Affiliations

HER-2 Evaluation in a Specific Gastric Cancer Population with the Highest Rate of Mortality in Spain

E U Cidon et al. J Oncol. 2011.

Abstract

Gastric cancer (GC) still represents the second cause of cancer-related death worldwide. Radical resection is the mainstay of early stages treatment with little impact on overall survival (OS) in the advanced ones. HER-2 is the most relevant biological factor involved. Purpose. This study aims to show the relationship between HER-2 positivity and survival in patients with completely resected GC. Methods. Retrospective study of GC patients diagnosed in 2003-2005 at our institution. Surgical specimens underwent immunohistochemistry (IHC), and in cases +/++/+++ samples underwent also fluorescence in situ hybridisation (FISH) analyses of HER-2 and graduated according to experts' consensus. Results. 120 cases included. Overall expression detected in 7.5%. Correlation between HER-2 positive and female sex, advanced stages or histological grades, or intestinal type was detected. Early recurrences higher in HER-2 positive (66.6% versus 35.4%, P = 0.048). The median DFS for c-erbB-2 positive was 15 months (range 2-67 months), and OS was 25 months (range 10-67 months). In the case of patients with c-erbB-2, negative median DFS was 27 months (range 5-67 months) and OS for this sample is 47 months (range 29-67 months). Conclusions. These results emphasize the relevance of HER-2 positivity in GC as independent prognostic factor and support its current analyses in daily practice.

PubMed Disclaimer

References

    1. Layke JC, Lopez PP. Gastric cancer: diagnosis and treatment options. American Family Physician. 2004;69(5):1133–1145. - PubMed
    1. Archie V, Kauh J, Jones DV, Cruz V, Karpeh MS, Thomas CR. Gastric cancer: standards for the 21st century. Critical Reviews in Oncology/Hematology. 2006;57(2):123–131. - PubMed
    1. Van Cutsem E, Van de Velde C, Roth A, et al. Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)—gastrointestinal cancer group. European Journal of Cancer. 2008;44(2):182–194. - PubMed
    1. Shibata A, Parsonnet J. Stomach cancer. In: Schottenfeld D, Fraumeni JF Jr., editors. Cancer Epidemiology and Prevention. 3rd edition. Oxford, UK: Oxford University Press; 2006. pp. 707–720.
    1. Hamashima C, Shibuya D, Yamazaki H, et al. The Japanese guidelines for gastric cancer screening. Japanese Journal of Clinical Oncology. 2008;38(4):259–267. - PubMed